Two stem-cell transplants better than one in neuroblastoma

The trial including Australian patients 'has changed current practice', experts say

Two autologous stem-cell transplants provide better event-free survival in patients with high-risk neuroblastoma, compared with a single stem-cell transplant, a clinical trial shows.